Scientists have identified the genetic cause of a neurodevelopmental disorder resulting in intellectual disability, a condition estimated to affect as many as one in 20,000 young individuals. The breakthrough, published in Nature Medicine on Friday, offers hope for new diagnostic possibilities that could provide much-needed answers for affected families.
The disorder, marked by intellectual disability, is accompanied by a range of symptoms including short stature, small heads, seizures, and low muscle mass. Researchers from the Icahn School of Medicine at Mount Sinai, led by senior author Ernest Turro, emphasized the surprising prevalence of this disorder compared to other single-gene-linked rare diseases.
Subtle Symptoms Often Overlooked
Dr. Charles Billington, a pediatric geneticist at the University of Minnesota not involved in the study, noted that such syndromes often go unnoticed due to their subtle traits, making them difficult for doctors to identify purely through observation. He highlighted the importance of genetic research in recognizing and naming these conditions.
Non-Coding Gene Mutation Identified
The study pinpointed mutations in a small “non-coding” gene called RNU4-2, which does not provide instructions for making proteins. This discovery is notable as it differs from the majority of the nearly 1,500 genes linked to intellectual disability, which are protein-coding. Traditional sequencing technologies often overlook non-coding genes, but this research utilized comprehensive “whole-genome” sequencing data from the British 100,000 Genomes Project, encompassing 77,539 participants, including 5,529 with intellectual disabilities.
Implications for Diagnosis and Support
Andrew Mumford, research director of the South West England NHS Genomic Medicine Service and study author, stated that this finding “opens the door to diagnoses” for thousands of families. While the exact mechanism by which the RNU4-2 mutation causes the disorder remains unclear, and no treatment exists yet, the discovery paves the way for labs to offer testing for this condition.
Billington emphasized the potential for families to find support and reassurance through shared experiences, noting the comfort that comes from knowing they are not alone.
Looking Ahead
Further research is needed to understand how the RNU4-2 mutation leads to the disorder, but the study represents a significant step forward in the field of genetic research and diagnosis.
This article was generated with the assistance of artificial intelligence and reviewed by an editor.